CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$4.23
-0.02 (-0.47%)
âŧ
5d:
+3.17%
30d:
+0.0%
90d:
+1.2%
WAIT
LOW Confidence
Analysis Updated: Aug 27, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 25, 2026 at $4.13 · last confirmed Aug 26, 2026
Strength: 6.0/10
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CLOV is fairly priced but lacks strong directional signals. At -8.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CLOV is fairly priced but lacks strong directional signals. At -8.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $4.23, which is considered slightly low relative to its 30-day fair value range of $4.17 to $4.57. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.2) compared to its historical average (36.2). Remarkably, the market is currently pricing in an annual earnings decline of 8.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CLOV is in a strong uptrend. Immediate support is located at $4.04, while resistance sits at $4.63.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.17 (+22.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLOV is in a strong uptrend. Immediate support is located at $4.04, while resistance sits at $4.63.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.17 (+22.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.17 -
$4.57
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.1% below Wall St target ($5.17)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.17 -
$4.57
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.04
Resistance Level
$4.64
Current Trend
Strong Uptrend
Technical data as of
Aug 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.20
Wall Street Target
$5.17
(+22.1%)
Revenue Growth (YoY)
55.6%
Profit Margin
-0.7%
Valuation Discount vs History
-8.0% cheaper
PE vs Historical
28.2 vs 36.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.0%
(market-implied from PE analysis)
1-Year Target
$3.89
(-8%)
2-Year Target
$3.58
(-15%)
3-Year Target
$3.29
(-22%)
3-Yr Target (if PE normalizes)
(PE: 28â36)
$4.23
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.2, Growth: 7.1%)
$5.20
(+23%)
Base:
(SPY PE: 20.1, Growth: 7.1%)
$3.70
(-13%)
Bear:
(PE: 17.1, Growth: 7.1%)
$3.15
(-26%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.2 to 36.2
Stabilization Target:
$5.43
(+28.4%)
PE Expansion Potential:
+28.4%
Share & Embed Analysis
Last updated: August 27, 2026 9:18 PM ET
Data refreshes hourly during market hours. Next update: 10:18 PM
Data refreshes hourly during market hours. Next update: 10:18 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brady Patrick Priest
SELL
175000 shares
2026-03-04
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 76 BUY |
|
UNH
UnitedHealth Group IncorâĻ |
STRONG BUY
27 analysts |
$475 | 65 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 54 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$449 | 51 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$416 | 51 HOLD |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
